CPhI: The Pharma Awards winnersAt the CPhI Worldwide in Frankfurt, the winners of the 2019 Pharma awards were announced. The CEO of WuXi AppTec, Dr. Ge Li, received the award in category CEO of the year among 12 other categor … more ➔
Sustainable DNA extractionBioEcho develops single-spin and 96-well kits for the isolation of DNA from different starting materials. In contrast to common bind-wash-elute procedures their proprietary EchoLUTION single-step technology … more ➔
Long-term stabilization of assay component... Many users in research labs like to store their assay components such as assay antibodies, conjugates, antigens, calibrators or coated ELISA plates for a while without losing functionality. more ➔
Sequencing-ready DNA for fast Molecular Br...BioEcho develops single-spin and 96-well kits for the isolation of DNA from different starting materials. Their proprietary EchoLUTION single-step technology avoids the use of inhibitory process reagents … more ➔
Innovative analytical methods for particul... Manufacturers respond to stricter regulations with novel approaches. more ➔
Biotech company Galapagos improves high-co... Galapagoss mission is to develop first-in-class medicines based on the discovery of novel targets. Using human primary healthy andpatient cells, the company discovers which proteins play a key role … more ➔
Whitepaper Spotlight: Proactive Biomarker... Oncology drugs developed through a biomarker-guided precision medicine design are 38% more likely to be commercialized. But success relies on following a plan from the start — learn how in this … more ➔
LEA Jury announces the Winners of LEA 2019LEA, the Lipidomics Excellence Award, was founded to strengthen life sciences through lipidomics. Over the course of April, the LEA jury deliberated on the submitted projects to announce the three … more ➔
Inhibitor-free DNA Reliability for any... BioEcho develops single-spin and 96-well kits for the isolation of DNA. Their proprietary EchoLUTION single-step technology avoids the use of inhibitory process reagents resulting in increased sensitivity … more ➔
Reaching global markets Small- and medium-size European companies face the challenge of establishing global B2B activities in order to access relevant markets along the drug development value chain. YUMABs flexible business … more ➔
